The Offices of United States Senator Richard Burr and United States Senator Thom Tillis, the North Carolina Military Business Center, the North Carolina Biotechnology Center and the UNC System are pleased to host the Medical, Biomedical & Biodefense: Support to the Warfighter Symposium on June 12 in Chapel Hill, North Carolina.
WHEN. June 11 (evening welcome social at Durham Bulls Baseball) and June 12, 2019 (Symposium day)
WHERE. University of North Carolina – Chapel Hill
The Friday Conference Center
100 Friday Center Drive
Chapel Hill, North Carolina 27599
PARKING PASS. A parking pass is required. Parking passes will be provided closer to the event to print.
ABOUT THE EVENT:
Medical Support to the Warfighter, will connect businesses in North Carolina with military and other federal agencies that require or purchase medical supplies, equipment, devices, pharmaceuticals, medical information technology and medical services. Representatives from the Departments of Defense, Veterans Affairs and Health and Human Services, their prime vendors and major contractors – from national commands and from bases, commands and facilities in North Carolina – will highlight current technology or resource gaps and needs, future requirements and procurement processes to supply military and federal medical facilities and agencies. All medical-related businesses in North Carolina – large or small, prime contractors, subcontractors, suppliers, manufacturers and service providers – will benefit from briefings on military requirements, procurement processes and supplier qualifications, from informal networking with buyers and users, and from exhibiting or viewing demonstrations of the latest medical technologies designed to support America’s warfighters.
The Biomedical and Biodefense Support to the Warfighter portion of this conference will include sessions on the federal biodefense research and development (R&D) landscape, mechanisms for engaging the defense and military biomedical R&D community, and new models for driving innovation through public-private partnerships. In the first session, agency representatives from the Departments of Defense and Health and Human Services will discuss current interagency biodefense R&D priorities, perspectives, and collaborations. The second session will provide valuable insights from selected federal funding agencies and industry enablers on traditional and emerging approaches to defense R&D funding and support. The third session will feature representatives from several partnership-based R&D consortia and accelerators for biomedical and biodefense technology advancement. Each session will include presentations and panel discussions to foster awareness and dialogue among government, academic, and industry stakeholders in addressing the future biomedical and biodefense technology needs of the military and our nation.